Karyopharm Therapeutics SG&A Expense (TTM) Insights

Karyopharm Therapeutics, Inc. (KPTI)

7.45 +0.01 (+0.13%) USD | NASDAQ | Dec 24, 12:18

View SG&A Expense (TTM) for KPTI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (TTM) Benchmarks

Start Trial

TG Therapeutics, Inc.	208.25M
Actinium Pharmaceuticals, Inc.	15.79M
Axsome Therapeutics, Inc.	514.57M
Krystal Biotech, Inc.	136.75M
Akebia Therapeutics, Inc.	112.54M